Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study

BACKGROUND: Although the effects of interleukin-17A (IL-17A) inhibition on the signs and symptoms of psoriatic arthritis (PsA) are well defined, little is known about its impact of local inflammatory and structural changes in the joints. The PSARTROS study was designed to elucidate the effects of IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Kampylafka, Eleni, d’Oliveira, Isabelle, Linz, Christina, Lerchen, Veronika, Stemmler, Fabian, Simon, David, Englbrecht, Matthias, Sticherling, Michael, Rech, Jürgen, Kleyer, Arnd, Schett, Georg, Hueber, Axel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063019/
https://www.ncbi.nlm.nih.gov/pubmed/30053825
http://dx.doi.org/10.1186/s13075-018-1653-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063019/
https://www.ncbi.nlm.nih.gov/pubmed/30053825
http://dx.doi.org/10.1186/s13075-018-1653-5

Ejemplares similares